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RESEARCH ARTICLE
Effects of Antiepileptic Drugs on Electroencephalographic Findings in Patients 
with Idiopathic Generalized Epilepsy
Abstract
Objective 
Several antiepileptic drugs (AEDs) such as phenobarbital (Pb), carbamazepine 
(CBZ), and valproate (VPA) may suppress interictal epileptiform activity. We 
investigated the effects of AEDs on electroencephalography (EEG) data from 
patients with idiopathic generalized epilepsy (IGE).
Materials & Methods
In this cross-sectional study, all patients electroclinically diagnosed with 
IGE were recruited in the outpatient epilepsy clinic at Shiraz University of 
Medical Sciences from September 2008 through August 2010. A routine EEG 
was requested at the time of referral for all patients. Statistical analyses were 
performed using Chi square and Fisher’s exact test. 
Results
This study comprised of 336 patients. For about 20.8% (70 patients) of them, the 
initial EEG appeared normal. The first EEG was normal in 14.2% of the patients 
who had newly diagnosed IGE (19 patients). Normal EEG was also detected for 
27.6% of the patients who received VPA monotherapy (16 patients), 31% of the 
patients who received CBZ monotherapy (9 patients), 29.4% of the patients who 
received Pb monotherapy (5 patients), and 11.1% of the patients who received 
lamotrigine (LTG) (1 patient). 
Conclusion
This study shows that compared to LTG, VPA suppresses generalized interictal 
epileptiform activity in patients with IGE more effectively. Theoretically, if a 
drug can frequently induce normalization of EEG, then it may be a better drug 
for treating IGEs.
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Introduction
The electroencephalography (EEG) is a test that evaluates the brain’s electrical 
activity. EEG provides information on the presence or absence of abnormal electrical 
activity as well as information that aids in identification of the disorder and location of 
the seizure focus. EEG is particularly valuable for diagnosing idiopathic generalized 
epilepsy (IGE). However, EEG has some limitations. For example, EEG results of 
some patients with IGE may be normal (1). In addition, several factors may affect 
the rate and appearance of interictal epileptiform discharges. Several antiepileptic 
drugs (AEDs) such as phenobarbital (Pb), carbamazepine (CBZ), valproate (VPA), 
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and levetiracetam may suppress interictal epileptiform 
activity (2-4). In this study, we investigated the impact of 
AEDs on EEG data of patients with IGE. Theoretically, 
this effort may help in the identification of the best 
possible therapy for patients with IGE.
Materials & Methods
In this cross-sectional study, all patients who were 
electro-clinically diagnosed with IGE were recruited 
in the outpatient epilepsy clinic at Shiraz University of 
Medical Sciences (the only epilepsy clinic in southern 
Iran) from 2008 to 2010. The epilepsy diagnosis was 
based on clinical and EEG findings, and all patients 
were required to be under the care of our institution’s 
epileptologist. The inclusion criteria had no age 
constraints, and a routine EEG was requested for all 
patients at the time of referral. To evaluate the effects 
of AEDs on EEG activity, we classified the patients 
into 6 different groups according to the drug status of 
the patients at the time of referral to our clinic. The 6 
groups consisted of patients who were receiving (1) no 
AED therapy (newly diagnosed), (2) VPA therapy, (3) 
lamotrigine (LTG) therapy, (4) CBZ therapy, (5) Pb 
therapy, and (6) any other AED(s) therapy or polytherapy 
at the time of referral. We excluded the last group from 
the statistical analysis because of its small numbers and 
confounding results.
Each patient’s age, gender, age at seizure onset, seizure 
type(s), and EEG results were recorded. The study 
population was characterized by descriptive summary 
of demographic variables and relevant clinical and EEG 
variables. Statistical analyses were performed using Chi 
square and Fisher’s exact tests to determine significance 
of differences; P < 0.05 was considered significant. This 
study was approved by the Shiraz University of Medical 
Sciences Review Board.
Results
During the 2-year study period, 1640 epilepsy patients 
were registered at our epilepsy clinic. Of these patients, 
344 (21%) were diagnosed with IGE. Of these, 336 
(97.7%) patients had an EEG done at our clinic and 
participated the study. They consisted of 199 (59.2%) 
female patients and 137 (40.8%) male patients. The age 
of seizure onset was 12.3 ± 6.8 years (range, 1-47 years). 
The group of patients receiving no AED therapy (newly 
diagnosed) comprised of 134 patients (39.9%). Of the 
remaining patients, 58 (17%) were receiving VPA, 29 
(8.6%) were receiving CBZ, 17 (5%) were receiving Pb, 
9 (2.6%) were receiving LTG alone, 15 were receiving 
LTG with or without other drugs (other than VPA), and 
38 (11.3%) were receiving VPA and LTG. Only 7 patients 
were taking topiramate therapy, and most of them, 
received topiramate as a part of a polytherapy. None of 
the patients received levetiracetam or zonisamide since 
these drugs are not easily available in Iran. 
The results of the first EEG performed in this study were 
normal for 20.8% (70) of the patients. The first EEG was 
normal in 14.2% (19) of the patients with newly diagnosed 
IGE, 27.6% (16) of patients in the VPA monotherapy 
group (P = 0.027), 31% (9) of patients in the CBZ 
monotherapy group (P = 0.029), 29.4% (5) of patients in 
the Pb monotherapy group (P = 0.1), and one patient in 
the LTG group (P = 0.8). The frequencies of various EEG 
abnormalities were not significantly different among the 
different therapy groups (isolated polyspikes, P = 0.25; 
3-Hz generalized spike-waves ± polyspikes, P = 0.16; 
and 3.5-6 Hz generalized spike-waves ± polyspikes, 
P= 0.28). A comparison between EEG abnormalities in 
patients with newly diagnosed IGE and patients on VPA 
monotherapy is shown in Table 1. A photoparoxysmal 
response (PPR) was observed in 11 patients (8.2%) who 
received no AED (newly diagnosed IGE), 2 patients 
(3.4%) who received VPA therapy, 5 patients (33.3%) 
who received LTG, 4 patients who received both VPA 
and LTG, 1 patient (5.8%) who received Pb, and in none 
of the patients who received CBZ. The frequency of PPR 
in patients who received LTG was significantly higher 
than that in patients who either were newly diagnosed 
(P = 0.01) or received VPA (P =0.01). This was also the 
case for patients who received LTG monotherapy; of the 
9 patients who received LTG monotherapy, 3 exhibited 
PPR. The differences in the frequencies of PRR in newly 
diagnosed patients and patients who received the other 
drugs were not statistically significant.
 
Discussion
EEG is a valuable tool for diagnosing IGE. The presence 
of generalized spike-wave complexes and/or polyspikes 
increases the probability that IGE will be diagnosed 
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correctly. However, the use of EEG for diagnosing 
IGE has several limitations. First, EEG results of some 
patients may be normal. We observed that the results 
of first EEGs of about 1/5 (20%) of our patients were 
normal; this rate was 45% in a previous study (1). This 
difference may be due to the different methods used 
during the EEG recordings (e.g., if the filter setting in the 
EEG machine is set below 70 Hz, then the designated high 
filter may improperly filter some spikes or polyspikes) or 
this difference could be reader dependent. Compared to 
patients who received LTG, patients who received VPA 
showed a higher frequency of normal EEG; this indicates 
that VPA suppresses generalized interictal epileptiform 
activity in IGE patients more effectively than LTG. 
However, the differences between patients who received 
VPA and CBZ and between patients who received VPA 
and Pb were not significant either. In a previous study 
(2), EEG pairs were identified such that the first tracing 
illustrated interictal epileptiform activity before AED 
therapy was initiated. The rate of clearance of interictal 
epileptiform activity was assessed in the subsequent 
tracing depending on the drug introduced. EEG pairs 
(n = 213) were identified in patients who received CBZ 
(55 patients), Pb (81 patients), and VPA (77 patients). 
Overall, the suppression rates of epileptiform activity 
in the second EEG were 22% for Pb, 33% for CBZ, 
and 46% for VPA (P = 0.005 for VPA versus Pb). In a 
small study, levetiracetam was observed to significantly 
reduce the epileptiform discharges in the add-on therapy 
group, but not in the monotherapy group (3). In another 
small study (8 patients), the authors evaluated the results 
of continuous EEG of patients with refractory IGE. Four 
patients received levetiracetam as an add-on therapy, 
and in four a conversion to levetiracetam monotherapy 
was undergone. In that study, epileptic activity was 
analyzed to determine the spike-wave density (spikes/h) 
and median and maximal duration of spike-wave 
discharges. Each patient was monitored for 24 hours via 
EEG before levetiracetam therapy was initiated. Patients 
were monitored again for 24 hours via EEG after a mean 
follow-up period of 136 days. Spike-wave density was 
reduced by 78% following levetiracetam administration, 
and the median spike-wave duration decreased by 72% 
(P < 0.05) (4). In a case report, a patient with juvenile 
myoclonic epilepsy demonstrated complete resolution 
of myoclonic jerks, absence, and generalized seizures 
after zonisamide therapy was initiated; his EEG showed 
near complete resolution of generalized spike-wave 
discharges after the drug was introduced (5). Additional 
studies should be conducted to compare the effects of 
VPA with new AEDs on the EEG findings in patients with 
IGE. In theory, this may help identify the best possible 
therapy for these patients, particularly in the refractory 
cases. In other words, if a drug normalizes EEGs with 
increased frequency, then it may be the preferred drug 
for patients with IGE.
In our study, the frequency of PRR for patients in the 
LTG group was significantly more than that for patients 
who either were newly diagnosed or received VPA. 
PPR occurred with increased frequency in the newly 
diagnosed patients than in patients who received VPA, 
however, this difference was not significant. VPA 
has been recommended as the first choice of AED 
for photosensitive patients (6); this is in concordance 
with our findings. VPA monotherapy has been shown 
to be successful in 73%-86% of the treated patients. 
Levetiracetam is an alternative for patients with IGE 
and photosensitivity; however, we could not investigate 
the effects of levetiracetam because none of our 
patients received this drug. In the literature, clobazam, 
lamotrigine, ethosuximide, and topiramate have also 
been recommended as second choices (6). We cannot 
provide a definite explain for the increased PPR 
frequency in LTG group compared to newly diagnosed 
patients; however, the small number of patients may 
be a potential reason for this difference. LTG should 
be prescribed carefully until further investigations are 
conducted that clarify the effectiveness of this drug in 
photosensitive patients.
In conclusion, This study indicates that VPA 
suppresses generalized interictal epileptiform activity in 
patients with IGE more effectively than LTG. In theory, 
a drug that can normalize abnormal EEGs with increased 
frequency may be a better drug. Thus, we suggest that 
VPA should be the first choice AED for IGE patients, 
particularly for patients with photosensitivity. However, 
LTG should be the first choice of AED for young women 
because of the potential side effects of VPA (7).
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Limitations of the study
a) This was a clinic-based study, and our data may not 
represent the full spectrum of IGE because patients 
with mild disease varieties are not always referred to 
a university clinic. However, the large sample size and 
the fact that our center is the only epilepsy center in the 
region may overcome this problem to some extent. Of 
course, selection bias is always a limitation of this type 
of study. 
b) Some groups comprised of a small number of patients, 
which could affect the results.
c) We did not compare the pre- and post-antiepileptic 
drug therapy EEGs in this study. We think that additional 
studies should be performed to precisely evaluate the 
effects of various AEDs on EEG data from patients.
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Table 1: Electroencephalographic (EEG) abnormalities in patients who were newly diagnosed with idiopathic generalized 
epilepsy (IGE) and patients who received valproate (VPA)
EEG Findings Newly Diagnosed IGE (n = 134) VPA Group (n = 58) P value
3.5-6 Hz Generalized spike wave (GSW) 28 6 0.079
3.5-6 Hz GSW + Polyspikes 25 13 0.549
3 Hz GSW 22 7 0.440
3 Hz GSW + Polyspikes 20 11 0.485
Normal 19 16 0.027
Polyspikes 12 4 0.780
Photoparoxysmal response only 5 0 0.325
Asynchronous F3 & F4 spikes 2 0 1.000
Focal slow waves 1 1 0.514
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